CAPTRUST Financial Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $198K | Buy |
|
|||||
|
2025
Q1 | $154K | Buy |
|
|||||
|
2024
Q4 | $124K | Buy |
|
|||||
|
2024
Q3 | $124K | Buy |
|
|||||
|
2024
Q2 | $84.2K | Buy |
|
|||||
|
2024
Q1 | $67.5K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $68K | Sell |
|
|||||
|
2022
Q1 | $107K | Buy |
|
|||||
|
2021
Q4 | $87K | Sell |
|
|||||
|
2021
Q3 | $112K | Buy |
|
|||||
|
2021
Q2 | $82K | Hold |
|
|||||
|
2021
Q1 | $53K | Sell |
|
|||||
|
2020
Q4 | $44K | Sell |
|
|||||
|
2020
Q3 | $25K | Buy |
|
|||||
|
2020
Q2 | $17K | Buy |
|